The FDA disappointed AstraZeneca and its investors by not approving its heart drug Brilinta, a blood-thinner that the company — facing a severe patent cliff — has high hopes for. If approved, it could be a multibillion-dollar…
Shipping company FedEx (FDX), often seen as a bellwether of the economy, reported Wednesday that net income in its fiscal 2011 second-quarter declined 18% from a year ago period, even as revenue climbed 12%. Both income and revenue missed Wall Street e…
FedEx will likely show an increase in fiscal second-quarter earnings of about 20% from a year earlier when it releases its latest report on Thursday. The huge air-cargo carrier is looking for a jump in revenue to more than offs…
More than a year after AstraZeneca filed for approval, the FDA will make its decision on Thursday. A large study showed the blood thinner worked better than Plavix for treating acute coronary syndrome — but approval isn’t a su…
Power plant operator Dynegy has agreed to be acquired by Icahn Enterprises for $5.50 per share in cash, or about $665 million. Dynegy has about $3.95 billion of outstanding debt, net of cash. The agreement follows a recent fail…